TeleCare vs CellPoint

You can now use the " TeleCare app" to manage your health. (We recommend you also download the "Chiline HomeCare app" for more comprehensive health data.) Product highlights: Comprehensive data Long-term data recording for better health management New way to keep records Files auto uploaded to the cloud for permanent storage Data at your hand Detailed records for easy understanding of your health 【Statement of Jurisdiction】 Inventec Corporation (hereinafter "the Company") is the owner of this app, which is to be used with Chiline Blood Pressure Monitor, Chiline Blood Glucose/Total Cholesterol/Uric Acid Monitoring System, and Chiline ECG Recorder (hereinafter "medical devices"). The Company is the manufacturer of the medical devices mentioned above. Each medical device has received its medical device license from the Ministry of Health and Welfare in Taiwan. The license numbers are as follows: Chiline Blood Pressure Monitor: MOHW-MD-No. 006444 Chiline Blood Glucose/Total Cholesterol/Uric Acid Monitoring System: MOHW-MD-No. 006490 Chiline ECG Recorder: MOHW-MD-No. 006588 【Disclaimer】The goal of the operator has always been to provide useful information to you and/or the product user, and to encourage you and/or the product user to live a healthy lifestyle. Before you and/or the product user start using this product and its related services, or before changing your exercise plans, please consult your physician for professional advice. The TeleCare App can be used in conjunction with Apple Health to synchronize steps and sleep data.

The CellPoint application has been developed for oncology patients enrolled in CellPoint CAR-T therapies at the point-of-care. The CellPoint application can be linked to the CardioWatch 287-2B bracelet. This bracelet and the application are intended for continuous monitoring of vital signs and capturing questionnaires throughout the patient’s treatment with CAR-T therapies. The CardioWatch 287-2B is a medically certified wireless remote monitoring system intended for continuous collection of vital parameters in home and in healthcare settings. CardioWatch 287 is a CE medical device certified under EU-MDR standards.  Data is transmitted wirelessly from the device via the application to the health cloud where it is stored and made available for further analysis. About CellPoint CellPoint, a Galapagos company, is dedicated to developing CAR-T therapies at the point-of-care, making these therapies more affordable and accessible to patients. CellPoint has developed a rapid manufacturing process, powered by its proprietary xCellit real-time monitoring software system, that allows for 1 week vein-to-vein time compared to over one month with current industry manufacturing platforms. A first proprietary CD19 CAR-T investigational therapy is currently in Phase1/2a trials to provide fast clinical validation of the decentralized point-of-care production model. More information at www.cellpoint.bio.  This application is only supported by phones with Bluetooth® 5.0 Low Energy. For Non European customers, CardioWatch 287 is available as Investigative device to collect body metrics data.  The device is not used for medical diagnostic or treatment. No physical harm risk.